In our study, we sought to investigate the role of CD44 in the regulation of tumor cell immune evasion and immune cell infiltration, as well as provide novel clues for administering immunotherapy to BLCA patients. This evidence concerns the gene CD44 and bladder transitional cell carcinoma.